Sarcoma botryoides

WikiDoc Resources for Sarcoma botryoides
Articles
Most recent articles on Sarcoma botryoides Most cited articles on Sarcoma botryoides Review articles on Sarcoma botryoides Articles on Sarcoma botryoides in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Sarcoma botryoides Images of Sarcoma botryoides Photos of Sarcoma botryoides Podcasts & MP3s on Sarcoma botryoides Videos on Sarcoma botryoides
Evidence Based Medicine
Cochrane Collaboration on Sarcoma botryoides Bandolier on Sarcoma botryoides TRIP on Sarcoma botryoides
Clinical Trials
Ongoing Trials on Sarcoma botryoides at Clinical Trials.gov Trial results on Sarcoma botryoides Clinical Trials on Sarcoma botryoides at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Sarcoma botryoides NICE Guidance on Sarcoma botryoides NHS PRODIGY Guidance FDA on Sarcoma botryoides CDC on Sarcoma botryoides
Books
Books on Sarcoma botryoides
News
Sarcoma botryoides in the news Be alerted to news on Sarcoma botryoides News trends on Sarcoma botryoides
Commentary
Blogs on Sarcoma botryoides
Definitions
Definitions of Sarcoma botryoides
Patient Resources / Community
Patient resources on Sarcoma botryoides Discussion groups on Sarcoma botryoides Patient Handouts on Sarcoma botryoides Directions to Hospitals Treating Sarcoma botryoides Risk calculators and risk factors for Sarcoma botryoides
Healthcare Provider Resources
Symptoms of Sarcoma botryoides Causes & Risk Factors for Sarcoma botryoides Diagnostic studies for Sarcoma botryoides Treatment of Sarcoma botryoides
Continuing Medical Education (CME)
CME Programs on Sarcoma botryoides
International
Sarcoma botryoides en Espanol Sarcoma botryoides en Francais
Business
Sarcoma botryoides in the Marketplace Patents on Sarcoma botryoides
Experimental / Informatics
List of terms related to Sarcoma botryoides

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Synonyms and keywords: Synonym 1; Synonym 2; Synonym 3

Historical Perspective

• Sarcoma botryoides was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
• In [year], [gene] mutations were first identified in the pathogenesis of sarcoma botryoides.
• In [year], the first [discovery] was developed by [scientist] to treat/diagnose sarcoma botryoides.

Classification

• Sarcoma botryoides may be classified according to [classification method] into [number] subtypes/groups:

• [group1]
• [group2]
• [group3]

• Other variants of sarcoma botryoides include [disease subtype 1], [disease subtype 2], and [disease subtype 3].

Pathophysiology

• The pathogenesis of sarcoma botryoides is characterized by [feature1], [feature2], and [feature3].
• The [gene name] gene/Mutation in [gene name] has been associated with the development of sarcoma botryoides, involving the [molecular pathway] pathway.
• On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of sarcoma botryoides.
• On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of sarcoma botryoides.

Causes

• Sarcoma botryoides may be caused by either [cause1], [cause2], or [cause3].
• Sarcoma botryoides is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
• There are no established causes for sarcoma botryoides.

Differentiating sarcoma botryoides from other Diseases

• Sarcoma botryoides must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:

• [Differential dx1]
• [Differential dx2]
• [Differential dx3]

Epidemiology and Demographics

• The prevalence of sarcoma botryoides is approximately [number or range] per 100,000 individuals worldwide.
• In [year], the incidence of sarcoma botryoides was estimated to be [number or range] cases per 100,000 individuals in [location].

Age

• Patients of all age groups may develop sarcoma botryoides.

• Sarcoma botryoides is more commonly observed among patients aged [age range] years old.
• Sarcoma botryoides is more commonly observed among [elderly patients/young patients/children].

Gender

• Sarcoma botryoides affects men and women equally.

• [Gender 1] are more commonly affected with sarcoma botryoides than [gender 2].
• The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

• There is no racial predilection for sarcoma botryoides.

• Sarcoma botryoides usually affects individuals of the [race 1] race.
• [Race 2] individuals are less likely to develop sarcoma botryoides.

Risk Factors

• Common risk factors in the development of sarcoma botryoides are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

• The majority of patients with sarcoma botryoides remain asymptomatic for [duration/years].
• Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
• If left untreated, [#%] of patients with sarcoma botryoides may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
• Common complications of sarcoma botryoides include [complication 1], [complication 2], and [complication 3].
• Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with sarcoma botryoides is approximately [#%].

Diagnosis

Diagnostic Criteria

• The diagnosis of sarcoma botryoides is made when at least [number] of the following [number] diagnostic criteria are met:

• [criterion 1]
• [criterion 2]
• [criterion 3]
• [criterion 4]

Symptoms

• Sarcoma botryoides is usually asymptomatic.
• Symptoms of sarcoma botryoides may include the following:

• [symptom 1]
• [symptom 2]
• [symptom 3]
• [symptom 4]
• [symptom 5]
• [symptom 6]

Physical Examination

• Patients with sarcoma botryoides usually appear [general appearance].
• Physical examination may be remarkable for:

• [finding 1]
• [finding 2]
• [finding 3]
• [finding 4]
• [finding 5]
• [finding 6]

Laboratory Findings

• There are no specific laboratory findings associated with sarcoma botryoides.

• A [positive/negative] [test name] is diagnostic of sarcoma botryoides.
• An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of sarcoma botryoides.
• Other laboratory findings consistent with the diagnosis of sarcoma botryoides include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

• There are no [imaging study] findings associated with sarcoma botryoides.

• [Imaging study 1] is the imaging modality of choice for sarcoma botryoides.
• On [imaging study 1], sarcoma botryoides is characterized by [finding 1], [finding 2], and [finding 3].
• [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

• Sarcoma botryoides may also be diagnosed using [diagnostic study name].
• Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

• There is no treatment for sarcoma botryoides; the mainstay of therapy is supportive care.

• The mainstay of therapy for sarcoma botryoides is [medical therapy 1] and [medical therapy 2].
• [Medical therapy 1] acts by [mechanism of action1].
• Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

• Surgery is the mainstay of therapy for sarcoma botryoides.
• [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of sarcoma botryoides.
• [Surgical procedure] can only be performed for patients with [disease stage] sarcoma botryoides.

Prevention

• There are no primary preventive measures available for sarcoma botryoides.

• Effective measures for the primary prevention of sarcoma botryoides include [measure1], [measure2], and [measure3].

• Once diagnosed and successfully treated, patients with sarcoma botryoides are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].

References

[[Category: Oncology]